Wong Rachel, Ziegler Jennifer, Bal Dhiraj S, Lother Sylvain A, Patel Premal, Rush Barret
Department of Surgery, Section of Urology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Department of Medicine, Section of Critical Care Medicine, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
J Assoc Med Microbiol Infect Dis Can. 2024 Jun 3;9(2):73-81. doi: 10.3138/jammi-2023-0030. eCollection 2024 Jun.
Sepsis secondary to obstructive uropathy is a urological emergency that requires urgent decompression using placement of a percutaneous nephrostomy tube (PCN) or retrograde ureteric stent (RUS). Whether selection of PCN or RUS impacts mortality remains uncertain.
We conducted a retrospective cohort analysis using the 2006-2014 Nationwide Inpatient Sample (NIS) of 34,009 patients with sepsis and obstructive uropathy who were treated with RUS or PCN. The primary outcome was in-hospital mortality. Secondary outcomes included hospital length of stay, need for mechanical ventilation, and need for dialysis. Multivariate logistic regression and propensity matched analyses were used to evaluate the effect of PCN or RUS on in-hospital mortality.
A total of 9,828 (28.9%) patients were treated with PCN and 24,181 (71.1%) with RUS. The unadjusted mortality for PCN and RUN patients was 5.3% and 2.8%, respectively. Those treated with PCN had a higher likelihood of requiring mechanical ventilation or hemodialysis. In the multivariate logistic regression analysis, RUS had lower odds of mortality compared to PCN (OR 0.72; 95% CI 0.63 to 0.83, < 0.01). After propensity score matching, the mortality for the RUS group was 3.4% and 4.0% for the PCN group ( = 0.19).
There were no significant differences in mortality for patients treated with PCN versus RUS after propensity matching. Method of decompression should be guided by local practice. Further prospective randomized trials are needed.
梗阻性尿路病继发的脓毒症是一种泌尿外科急症,需要通过放置经皮肾造瘘管(PCN)或逆行输尿管支架(RUS)进行紧急减压。PCN或RUS的选择是否会影响死亡率仍不确定。
我们使用2006 - 2014年全国住院患者样本(NIS)对34009例接受RUS或PCN治疗的脓毒症和梗阻性尿路病患者进行了回顾性队列分析。主要结局是住院死亡率。次要结局包括住院时间、机械通气需求和透析需求。采用多因素逻辑回归和倾向匹配分析来评估PCN或RUS对住院死亡率的影响。
共有9828例(28.9%)患者接受了PCN治疗,24181例(71.1%)接受了RUS治疗。PCN组和RUS组患者未经调整的死亡率分别为5.3%和2.8%。接受PCN治疗的患者更有可能需要机械通气或血液透析。在多因素逻辑回归分析中,与PCN相比,RUS的死亡几率更低(比值比0.72;95%置信区间0.63至0.83,P<0.01)。倾向评分匹配后,RUS组的死亡率为3.4%,PCN组为4.0%(P = 0.19)。
倾向匹配后,接受PCN与RUS治疗的患者死亡率无显著差异。减压方法应根据当地实际情况指导。需要进一步进行前瞻性随机试验。